EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY-NC-ND 4.0

What Deprescribing Information Should Be Communicated on Discharge and How? A Qualitative Study of Pharmacists' Perspectives on Deprescribing at Transitions of Care

Katherine Desforges, Aili V Langford, Aisling M McEvoy, Majd Abu Al Shieh, Justin P Turner, Michael Dooley, Cristina P Roman, Emily Reeve iD

Australasian Journal on Ageing · 2026-06 · 45 (2)

DOI: 10.1111/ajag.70173 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Australasian Journal on Ageing, online erschienen am 04.05.2026. Verfasst von Katherine Desforges und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Pharmacists, Deprescriptions, Patient Discharge, Attitude of Health Personnel. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council Investigator Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hospitalisation provides an opportunity to deprescribe (withdraw inappropriate medications), however, safe and effective deprescribing relies on good communication between relevant stakeholders. The aim of this study was to explore the perspectives of Australian hospital and community pharmacists on communicating information about deprescribing at transitions of care and their role in the deprescribing process.

Methods

A diverse group of hospital and community pharmacists was purposively recruited. Data were collected via individual semi‐structured interviews and focus groups that were audio‐recorded and transcribed verbatim using NVivo. Each transcript was thematically analysed using an inductive coding approach, performed by two independent coders.

Results

Thirty‐two pharmacists were recruited between June and August 2023. Seventeen participants worked in hospitals, 10 in community pharmacies, and five across both settings. Four themes with 12 subthemes were identified, pertaining to (i) how pharmacists communicate about deprescribing on hospital discharge, (ii) how pharmacists collaborate with other healthcare professionals and patients to optimise deprescribing, (iii) how the role of the pharmacist in deprescribing at transitions of care can be optimised, and (iv) how pharmacists feel about their current and future role in deprescribing.

Conclusions

Challenges in communicating deprescribing recommendations and ensuring continuity of care when patients transition between care settings were identified. Development of new tools (e.g., templates and guidance on how and what should be communicated) and processes to support communication at the transition of care from hospital to the community are needed to support deprescribing activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsDeprescriptionsPatient DischargeAttitude of Health PersonnelCommunicationPatient TransferHumansQualitative ResearchFemaleProfessional RoleMaleAustraliaAdultMiddle AgedFocus GroupsCommunity Pharmacy ServicesPharmacy Service, Hospital

Stichwörter der Autor:innen

community healthcaredeprescribinghospitalspharmaciststransition of care

Autor:innen und Institutionen

  • Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
  • Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
  • Department of Pharmacy, McGill University Health Centre, Montréal, Québec, Canada.
  • Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Faculty of Pharmacy, Université Laval, Québec, Québec, Canada.
  • Department of Pharmacy, Alfred Health, Melbourne, Victoria, Australia.

ORCID-Profile: Emily Reeve

Förderung

  • National Health and Medical Research Council Investigator Grant

Zitieren

APA

Desforges, K., Langford, A. V., McEvoy, A. M., Al Shieh, M. A., Turner, J. P., Dooley, M., Roman, C. P., & Reeve, E. (2026). What Deprescribing Information Should Be Communicated on Discharge and How? A Qualitative Study of Pharmacists' Perspectives on Deprescribing at Transitions of Care. Australasian Journal on Ageing, 45(2). https://doi.org/10.1111/ajag.70173

Vancouver

Desforges K, Langford AV, McEvoy AM, Al Shieh MA, Turner JP, Dooley M, et al. What Deprescribing Information Should Be Communicated on Discharge and How? A Qualitative Study of Pharmacists' Perspectives on Deprescribing at Transitions of Care. Australasian Journal on Ageing. 2026;45(2). doi:10.1111/ajag.70173

BibTeX
@article{Desforges2026,
  author = {Desforges, Katherine and Langford, Aili V and McEvoy, Aisling M and Al Shieh, Majd Abu and Turner, Justin P and Dooley, Michael and Roman, Cristina P and Reeve, Emily},
  title = {What Deprescribing Information Should Be Communicated on Discharge and How? A Qualitative Study of Pharmacists' Perspectives on Deprescribing at Transitions of Care},
  journal = {Australasian Journal on Ageing},
  year = {2026},
  volume = {45},
  number = {2},
  doi = {10.1111/ajag.70173}
}
Kostenlos starten →